Powered by

Can-Fite Reports Second Quarter 2019 Financial Results & Provides Clinical Update

Aug 29, 2019 - Business Wire
Financial Results

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced financial results for the six months ended June 30, 2019.

Clinical Development and Corporate Highlights During Q2 2019 Include:

Received Payments for New Distribution Deals for Piclidenoson and Namodenoson in South Korea - During the second quarter, Chong Kun Dang Pharmaceutica...